Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1999 May-Jun;5(3):415–423. doi: 10.3201/eid0503.990312

Human rabies postexposure prophylaxis during a raccoon rabies epizootic in New York, 1993 and 1994.

J D Wyatt 1, W H Barker 1, N M Bennett 1, C A Hanlon 1
PMCID: PMC2640781  PMID: 10341178

Abstract

We describe the epidemiology of human rabies postexposure prophylaxis (PEP) in four upstate New York counties during the 1st and 2nd year of a raccoon rabies epizootic. We obtained data from records of 1,173 persons whose rabies PEP was reported to local health departments in 1993 and 1994. Mean annual PEP incidence rates were highest in rural counties, in summer, and in patients 10 to 14 and 35 to 44 years of age. PEP given after bites was primarily associated with unvaccinated dogs and cats, but most (70%) was not attributable to bites. Although pet vaccination and stray animal control, which target direct exposure, remain the cornerstones of human rabies prevention, the risk for rabies by the nonbite route (e. g., raccoon saliva on pet dogs' and cats' fur) should also be considered.

Full Text

The Full Text of this article is available as a PDF (358.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Centers for Disease Control and Prevention (CDC) Raccoon rabies epizootic--United States, 1993. MMWR Morb Mortal Wkly Rep. 1994 Apr 22;43(15):269–273. [PubMed] [Google Scholar]
  2. Currier R. W., 2nd, McCroan J. E., Dreesen D. W., Winkler W. G., Parker R. L. Epidemiology of antirabies treatment in Georgia, 1967-71. Public Health Rep. 1975 Sep-Oct;90(5):435–439. [PMC free article] [PubMed] [Google Scholar]
  3. Helmick C. G. The epidemiology of human rabies postexposure prophylaxis, 1980-1981. JAMA. 1983 Oct 21;250(15):1990–1996. [PubMed] [Google Scholar]
  4. Jenkins S. R., Winkler W. G. Descriptive epidemiology from an epizootic of raccoon rabies in the Middle Atlantic States, 1982-1983. Am J Epidemiol. 1987 Sep;126(3):429–437. doi: 10.1093/oxfordjournals.aje.a114674. [DOI] [PubMed] [Google Scholar]
  5. Krebs J. W., Strine T. W., Smith J. S., Noah D. L., Rupprecht C. E., Childs J. E. Rabies surveillance in the United States during 1995. J Am Vet Med Assoc. 1996 Dec 15;209(12):2031–2044. [PubMed] [Google Scholar]
  6. Martin R. J., Schnurrenberger P. R., Rose N. J. Epidemiology of rabies vaccinations of persons in Illinois, 1967-68. Public Health Rep. 1969 Dec;84(12):1069–1077. [PMC free article] [PubMed] [Google Scholar]
  7. Rupprecht C. E., Smith J. S., Fekadu M., Childs J. E. The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg Infect Dis. 1995 Oct-Dec;1(4):107–114. doi: 10.3201/eid0104.950401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Uhaa I. J., Dato V. M., Sorhage F. E., Beckley J. W., Roscoe D. E., Gorsky R. D., Fishbein D. B. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. J Am Vet Med Assoc. 1992 Dec 15;201(12):1873–1882. [PubMed] [Google Scholar]
  9. Winkler W. G., Kappus K. D. Human antirabies treatment in the United States, 1972. Public Health Rep. 1979 Mar-Apr;94(2):166–171. [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES